Health minister Greg Hunt says the government will work with the sector to "ensure" Australian patients access gene and cell therapies as Alnylam Pharmaceuticals, the company with the first approved RNA interference therapeutic, confirms it has no current plan to bring ONPATTRO to Australia.
Greg Hunt: Will work to 'ensure' patient access to gene and cell therapies
June 21, 2019 Latest NewsNews of the Day
Latest Video
New Stories
-
This debate over US tariffs might be the dumbest in PBS history
July 9, 2025 - - Latest News -
AusBiotech welcomes 27 new members in first half of 2025
July 9, 2025 - - Latest News -
Health spending under increasing pressure, as department looks to offsets
July 9, 2025 - - Latest News -
Consortium established to co-design new telehealth standards
July 8, 2025 - - Latest News -
South Australia expands flu vax availability in response to record outbreak
July 8, 2025 - - Latest News -
MedAdvisor restates focus on US following completion of ANZ business sale
July 8, 2025 - - Latest News -
More companies are exercising their rights, and they are perfectly entitled
July 7, 2025 - - Latest News